Effects of Dietary Habits on General and Abdominal Obesity in Community-dwelling Patients with Schizophrenia
Mina Kim1, Soo Jin Yang2, Hyang Hee Kim3, Anna Jo4, Min Jhon4, Ju-Yeon Lee4, Seung-Hyung Ryu4, Jae-Min Kim4, Young-Ran Kweon1, Sung-Wan Kim3,4
1Department of Nursing, Chonnam National University, Gwangju, 2Department of Food and Nutrition, Seoul Women’s University, Seoul, 3Gwangju Bukgu Community Mental Health Center, 4Department of Psychiatry, Chonnam National University Medical School, Gwangju, Korea
Correspondence to: Soo Jin Yang
Department of Food and Nutrition, Seoul Women’s University, 621 Hwarang-ro, Nowon-gu, Seoul 01797, Korea
E-mail: sjyang89@swu.ac.kr
ORCID: https://orcid.org/0000-0001-7892-7648

Sung-Wan Kim
Department of Psychiatry, Chonnam National University Medical School, 160 Baekseo-ro, Dong-gu, Gwangju 61469, Korea
E-mail: swkim@chonnam.ac.kr
ORCID: https://orcid.org/0000-0002-6739-2163
Received: May 24, 2021; Revised: July 11, 2021; Accepted: August 9, 2021; Published online: February 28, 2023.
© The Korean College of Neuropsychopharmacology. All rights reserved.

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Objective: To investigate the effects of dietary habits on general and abdominal obesity in community-dwelling patients with schizophrenia spectrum disorder according to sex.
Methods: A total of 270 patients with schizophrenia spectrum disorder registered at mental health welfare centers and rehabilitation facilities were recruited. General obesity was defined as a body mass index ≥ 30 kg/m2, and abdominal obesity was defined as a waist circumstance ≥ 90 cm in men and ≥ 85 cm in women. Dietary habits were evaluated using dietary guidelines published by the Korean Ministry of Health and Welfare. Demographic and clinical characteristics along with dietary habits and information related to obesity were collected. Factors related to obesity were evaluated separately by sex.
Results: Dietary habits differed according to sex, in that scores for healthy eating habits were lower in men than in women. In men, the prevalences of general and abdominal obesity were 17.0% and 37.3%, respectively. In women, the prevalences of general and abdominal obesity were 23.1% and 38.5%, respectively. Regression analysis showed that the scores of regular eating habits were negatively associated with general and abdominal obesity in men, and the scores of healthy eating habits were negatively associated with general and abdominal obesity in women.
Conclusion: Among patients with schizophrenia, regular eating habits might reduce the risk of obesity in men, and healthy eating habits might reduce the risk of obesity in women. Nutrition education should be provided to community- dwelling patients with schizophrenia to prevent obesity in this population.
Keywords: Abdominal obesity; Dietary habits; Eating; Metabolic syndrome; Obesity; Schizophrenia
INTRODUCTION

Obesity, a disease that carries a considerable socioeconomic burden, is an increasing health problem worldwide [1,2]. Obesity in patients with schizophrenia is a particularly important physical health problem, as the prevalence of obesity in this population is 1.5−2 times higher than that in the general population [3]. Obesity increases the risks of developing metabolic syndrome, diabetes, and cardiovascular disease and eventually decreases life expectancy [4,5]. In addition, obesity may reduce adherence to antipsychotic medications [6,7]. Because obesity in patients with schizophrenia may have negative impacts on physical health and treatment continuation, it is necessary to identify and manage the factors related to obesity.

Although the mechanism of developing obesity in patients with schizophrenia is not fully understood, some antipsychotic medications are reportedly associated with weight gain [8]. However, since patients with schizophrenia who are not treated with antipsychotic drugs also experience weight gain [9,10], non-drug factors may also be an important consideration. According to a study conducted in the general population, eating habits are related to obesity [11], and regular and healthy eating habits can reduce the risk of obesity [12]. Dietary habits are eating behaviors that have become automatic in daily life. These habits determine the quality and amount of food consumed and consequently affect health conditions such as obesity [13]. Patients with schizophrenia have poor eating habits, such as high intake of fat and low intake of vegetables and fruits [14,15]. However, studies confirming the relationship between eating habits and obesity in patients with schizophrenia are insufficient. Furthermore, dietary habits and the prevalence of obesity differ by sex [16,17]. Therefore, it is necessary to examine the relationship between dietary habits and obesity according to sex.

In general, body mass index (BMI) is used to evaluate obesity, including in patients with schizophrenia [18]. However, as an obesity index, BMI is limited in that it cannot provide information on the distribution and accumulation of fat; hence, waist circumference is suggested as an alternative. Waist circumference is related to visceral fat and is also an actual clinical indicator of metabolic syndrome [19,20]. Abdominal obesity in patients with schizophrenia is more strongly correlated with cardiovascular risk factors than is BMI [21]. However, most previous studies evaluated obesity based only on BMI and then identified related variables. Hence, additional studies that include abdominal obesity are needed.

Therefore, this study aimed to assess BMI and waist circumference as indicators of obesity in patients with schizophrenia and to determine the effects of eating habits on obesity according to sex. The goal of this study was to provide basis for the prevention and management of obesity in patients with schizophrenia.

METHODS

Participants

This study was conducted as part of the physical health examination project for registered members of mental health institutions conducted by the Gwangju Mental Health and Welfare Commission. Questionnaires and tests were conducted in cooperation with mental health welfare centers, addiction management integrated support centers, and social rehabilitation facilities in five districts of Gwangju. A total of 459 people were evaluated twice, in 2015 (first survey) and in 2018 (second survey). Inclusion criteria for this study were a diagnosis of schizophrenia spectrum disorder according to the Diagnostic and Statistical Manual of Mental Disorders 5th edition and age of 20−65 years. A total of 270 subjects met the inclusion criteria. The diagnoses of the subjects included in this study were schizophrenia (n = 255, 94.4%), schizoaffective disorder (n = 6, 2.2%), and other psychotic disorders (n = 9, 3.3%). This study was approved by the Biomedical Research Ethics Committee of Chonnam National University Hospital (CNUH-2018-127). All subjects provided written informed consent before partici-pation. The study was carried out in accordance with the latest version of the Declaration of Helsinki.

Measures

Subjects’ demographic, clinical, and dietary characteristics were collected from the results of health checkups provided by the National Health Insurance Service and self-reported questionnaires. Demographic characteristics included sex, age, education level, marital status, occupational status, and type of medical coverage. Clinical characteristics included diagnosis, duration of treatment, general severity, and type and dose of antipsychotic drugs in use. Symptom severity and functional impairments were evaluated by the case manager using a 7-point Likert scale according to the clinical global impression scale (CGI) [22]. In this study, the CGI scores were divided into mild (1−3 points), moderate (4−5 points), and severe (6−7 points) symptoms. The types and doses of antipsychotic drugs taken were investigated. Antipsychotic drugs were classified according to the potential risk of weight gain as follows: high risk (clozapine, olanzapine), intermediate risk (amisulpride, paliperidone, quetiapine, risperidone), and low risk (aripiprazole, ziprasidone, and haloperidol) [23]. If two or more antipsychotics were used, the case was classified based on the antipsychotic drug with the greater risk (e.g., the combination of risperidone and aripiprazole was classified in the intermediate class). The cumulative dosage of antipsychotics was transformed into the risperidone-equivalent dose [24].

Dietary habits were evaluated using questionnaire of dietary guidelines published by the Korean Ministry of Health and Welfare [25]. The questionnaire for dietary habits consisted of questions in three domains of eating habits: regular eating (five items), balanced eating (six items), and healthy eating (nine items) habits. Responses to the questions were based on a Likert scale. Specifically, regular eating habits were addressed by questions regarding eating at a regular time, eating various food groups at every meal, eating appropriate amounts, eating breakfast, and eating in a pleasant and relaxing atmosphere. Balanced eating habits were assessed by the intake frequency of each nutrient component. Healthy eating habits were assessed based on eating out/processed foods; consuming animal oil, salt, sugar, caffeine, and alcohol; and the frequency of smoking and exercise. Higher scores for a given subfactor indicated a diet that was more regular, balanced, or healthy.

Obesity was defined as a BMI ≥ 30 kg/m2 according to the World Health Organization (WHO) standards [26]. Abdominal obesity was defined as a waist circumference ≥ 90 cm for men and ≥ 85 cm for women based on the guidelines of the Korean Society for the Study of Obesity [27].

Statistical Analysis

Participants were divided into two groups according to the presence of general and abdominal obesity and by sex. Sociodemographic and clinical characteristics were compared between the groups using the independent ttest, Fisher’s exact test, or chi-squared test, as appro-priate. Logistic regression analyses were used to identify the effects of dietary habits on general and abdominal obesity after adjustment for variables that were associated with obesity at the p < 0.1 level in the univariate analyses and known associated factors (age and treatment duration). The data collected in this study were analyzed using IBM SPSS Statistics 25.0 (IBM Co., Armonk, NY, USA). All tests were two tailed, and the significance level was set at p < 0.05. 

RESULTS

A total of 270 patients with schizophrenia spectrum disorder (153 [56.7%] men, 117 [43.3%] women; mean age 40.4 ± 11.1 years) were enrolled in this study. There were no significant differences in demographic or clinical characteristics according to sex. Women exhibited significantly higher scores for healthy eating habits on the eating habit questionnaire compared with men (Table 1).

Among the men, 17.0% exhibited general obesity and 37.3% abdominal obesity. Table 2 shows comparisons of the general characteristics and dietary habits according to the presence of obesity in men. The general obesity group tended to have Medicaid insurance (p = 0.093) and to take higher doses of antipsychotics compared with the non-obesity group (p = 0.070). The type of antipsychotic used did not differ significantly with obesity. The total scores for dietary habits were lower in the general obesity group (p = 0.050) and the abdominal obesity group (p = 0.015) than in the non-obesity groups, although the difference between the general obesity group and the non-obesity group did not reach statistical significance. Specifi-cally, the general obesity group had a significantly lower score for regular eating habits (p = 0.003) and tended to have a lower score for balanced eating habits (p = 0.053). The abdominal obesity group showed significantly lower scores for regular eating (p = 0.017) and balanced eating habits (p = 0.034) compared with the non-obesity group.

Among the women, 23.1% had general obesity and 38.5% abdominal obesity. Table 3 shows comparisons of the general characteristics and dietary habits according to the presence of obesity in women. Those with general obesity compared with the non-obesity group were signifi-cantly more likely to be married (p = 0.030) and unemployed (p = 0.041). Scores for the healthy eating subfactor were significantly lower in the general obesity group than in the non-obesity group (p = 0.009). Patients in the abdominal obesity group were significantly older (p = 0.037) and tended to be married (p = 0.057) compared with those in the non-obesity group. The total score for dietary habits was significantly lower in the abdominal obesity group than in the non-obesity group (p = 0.014). Specifically, the score for healthy eating habits was significantly lower in the abdominal obesity group than in the non-obesity group (p = 0.033). Additionally, the score for balanced eating habits tended to be lower in the abdominal obesity group (p = 0.052).

Table 4 presents the results of the multivariate analysis of factors associated with general and abdominal obesity. In men, after adjusting for age, medical insurance, treatment duration, and antipsychotic dosage, regular eating habits were negatively associated with general (odds ratio [OR] = 0.8, 95% confidence interval [CI] = 0.7−0.9) and abdominal (OR = 0.9, 95% CI = 0.8−0.9) obesity. In women, after adjusting for age, marital status, employment status, and duration of treatment, healthy eating habits were negatively associated with general (OR = 0.8, 95% CI = 0.8−0.9) and abdominal (OR = 0.9, 95% CI = 0.8−0.9) obesity.

DISCUSSION

Obesity, a risk factor for metabolic syndrome, cardio-vascular disease, and premature death, is a frequent physical health problem in patients with schizophrenia spectrum disorder [3,5]. Because dietary habits determine the quality or quantity of foods an individual consumes [13], these habits represent a modifiable variable that can prevent or manage obesity. In this study, men had less healthy eating habits compared with women. Regular or healthy eating habits were found to influence general and abdominal obesity in patients with schizophrenia, and these effects differed by sex.

In this study, the prevalence of general obesity was 17.0% in men and 23.1% in women. These values are slightly higher than those in a previous French cohort survey of patients with schizophrenia (men 13.1%, women 21.7%) [8]. According to most existing research data, the prevalence of obesity in patients with schizophrenia is approximately 1.5−2 times higher than that in the general population [28]. The prevalence of obesity was 3−4 times higher in schizophrenia patients than in the general population aged ≥ 19 years in Korea (men 6.1%, women 5.4%) based on National Health and Nutrition Survey data [29]. The high prevalence of obesity among community-dwelling schizophrenia patients in community mental health institutions suggests the need for weight control strategies for this population.

BMI, an indicator of obesity, is mainly used as a general measure of obesity in patients with schizophrenia [18]. However, BMI is limited in that it cannot provide information on the distribution and accumulation of fat, so waist circumference has been suggested as an alternative measure. Waist circumference is related to visceral fat and is a clinical indicator of metabolic syndrome [19,20]. In the present study, the prevalence of abdominal obesity was 37.3% in men and 38.5% in women. Compared with the prevalence of abdominal obesity among adults in Korea (men 38.6%, women 30.2%), the prevalence in female patients with schizophrenia is higher. Abdominal obesity has a stronger correlation with cardiovascular risk factors than does BMI in patients with schizophrenia [21]. Therefore, it is necessary to include an easily applied waist circumference measure when monitoring obesity.

Some atypical antipsychotics play important roles in the development of obesity in patients with schizophrenia [23]. Many patients with schizophrenia complain that their medication causes weight gain, although they make no effort to pursue a healthy lifestyle to prevent obesity. In the present study, the classification of antipsychotics according to weight gain potential showed no significant association with obesity. Our study did not include all antipsychotics taken by the participants but rather only those taken at the time of the study. Therefore, any cumulative effects of antipsychotics taken before the study were not included. We should also consider the possibility that weight-neutral antipsychotics might be prescribed to patients with obesity. In addition, results showing that higher doses of antipsychotics tended to be associated with general obesity in male patients suggest the potential effects of antipsychotics on the development of obesity. However, statistically significant associations between eating habits and obesity also suggest the need for nutritional education aimed at modifying eating habits toward healthier patterns.

In men, regular eating habits were protective against general and abdominal obesity. Higher scores for the regular eating subfactor were achieved when respondents ate at regular times, including breakfast, with appropriate amounts at meals, and with a relaxed mind. According to previous studies, patients with schizophrenia ate more at meals, ate meals faster, and ate more frequent meals compared with the general population [30,31]. These irregular eating habits eventually create an excess energy balance, which affects obesity [28,29]. Skipping breakfast and irregular eating can cause binge eating and more between-meal snacks, which contribute to obesity [32]. Therefore, male patients with schizophrenia should be educated about the importance of regular eating three times a day of appropriately sized meals to prevent obesity.

In women, healthy eating habits were associated with general and abdominal obesity. Scores on the healthy eating subfactor were higher when respondents engaged in regular exercise and avoided instant foods or snacks, animal oils, sodium, sugars, three cups or more of caffeine, smoking, and alcohol. This result is similar to previous studies showing that patients with schizophrenia have relatively unhealthy eating habits, such as consuming animal fat, snacks, and instant foods, compared with the general population [33,34]. According to recent studies, obesity is associated with excessive caloric intake [35]. Snacks in the form of desserts and sweets are high in sugars and saturated fatty acids, which significantly increase caloric intake and lower protein or fiber intake [36]. Women tend to eat more sweets than men [37]. In addition, food cravings were associated with psychological variables such as depression and perceived stress in female patients with first-episode psychosis [38]. In general, depressive symptoms accompanied by chronic stress are associated with preferences for snacks/fast foods and sweets [39,40]. In women with schizophrenia, psychological factors such as stress may increase cravings for sweet foods, leading to obesity. Therefore, nutrition education for women with schizophrenia should include recommendations that they avoid eating too much fast food or stimulating foods and practice healthy eating behavior to prevent obesity.

On the other hand, the comparison of dietary habits according to sex revealed less healthy eating habits in men than women. Sex differences in eating patterns have also been noted in the general population [16]. Male patients with schizophrenia are more likely to consume alcohol than the general population [41], and their nicotine dependence is higher than that of women [42]. Healthy eating behaviors are also influenced by general dietary behaviors such as purchasing, processing, cooking, and ingesting foods [43]. Men are more vulnerable to unhealthy practices in these domains, which can lead to unhealthy eating habits.

This study has several limitations. First, the study population comprised mainly chronic patients who use mental health welfare centers and social rehabilitation facilities, which limits the generalizability of the study results to young patients or those in the early stages of the illness. In addition, the dietary habit scale was based on the subjects’ self-reports; objective assessments of eating behaviors and nutritional status should be included in future studies. Finally, this study did not include lifetime intakes of antipsychotic drugs because it was cross-sectional in design. However, our study findings indicating that modifiable eating habits could prevent obesity have important clinical implications. Clinicians working with patients with schizophrenia should try to foster better eating habits in an effort to prevent obesity among their patients.

Patients with schizophrenia have a higher prevalence of obesity compared with the general population due to the use of atypical antipsychotics and unhealthy lifestyles. Eating habits are modifiable factors that can help prevent or manage obesity. This study suggested that regular eating habits may prevent obesity in men with schizophrenia, and healthy eating habits may prevent obesity in women. Therefore, it is necessary to provide nutrition education programs in community mental health centers for the prevention and management of obesity in patients with schizophrenia [44].

Funding

This study was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF-2017R1A2B4010830).

Conflicts of Interest

No potential conflict of interest relevant to this article was reported.

Author Contributions

Conception and design of the study: Soo Jin Yang, Sung-Wan Kim. Acquisition of data: Mina Kim, Hyang Hee Kim, Min Jhon. Analysis of data: Mina Kim, Anna Jo, Soo Jin Yang. Writing−original draft: Mina Kim. Writing−editing: Soo Jin Yang, Sung-Wan Kim. Supervision: Ju-Yeon Lee, Seung-Hyung Ryu, Jae-Min Kim, Young-Ran Kweon. All authors reviewed the manuscript and approved it for submission.

Tables

Characteristics of the study population by sex

Characteristics Categories Total
(n = 270, 100%)
Men
(n = 153, 56.7%)
Women
(n = 117, 43.7%)
χ2 or t p value
Age Years 40.4 ± 11.1 40.7 ± 11.2 39.9 ± 11.1 0.578 0.564
Marital status Unmarried 249 (92.2) 144 (94.1) 105 (89.7) 1.768 0.184
Educationa ≤ 12 years 161 (60.8) 90 (59.6) 71 (62.3) 0.195 0.658
Employment statusa Unemployed 216 (82.1) 121 (81.8) 95 (82.6) 0.032 0.858
Medical insurancea Medicaid 138 (52.7) 79 (53.4) 59 (51.8) 0.068 0.794
Clinical Global Impressiona 1−3 98 (37.3) 61 (40.4) 37 (33.0) 2.984 0.225
4−5 152 (57.8) 85 (56.3) 67 (59.8)
6−7 13 (4.9) 5 (3.3) 8 (7.1)
Duration of treatment Years 15.4 ± 10.0 15.7 ± 9.8 15.1 ± 10.3 0.489 0.625
Dosage of antipsychoticsb mg/d 5.1 ± 4.0 4.8 ± 3.8 5.6 ± 4.3 −1.456 0.147
Weight-gain risk of currently used antipsychoticsa,c Low 35 (15.0) 19 (14.4) 16 (15.7) 1.527 0.466
Intermediate 144 (61.5) 78 (59.1) 66 (64.7)
High 55 (23.5) 35 (26.5) 20 (19.6)
Questionnaire for Dietary Habitsd Total 64.7 ± 13.2 63.4 ± 13.2 66.3 ± 13.0 −1.837 0.067
Regular 16.8 ± 6.4 16.6 ± 6.2 17.1 ± 6.5 −0.616 0.538
Balanced 14.4 ± 5.7 14.1 ± 5.5 14.7 ± 5.9 −0.768 0.443
Healthy 33.5 ± 6.6 32.6 ± 6.8 34.6 ± 6.2 −2.402 0.017

Values are presented as mean ± standard deviation or number (%).

aValid percent; bRisperidone equivalent dosage; cAntipsychotics included in each category: Low (aripiprazole, ziprasidone, and haloperidol), Intermediate (amisulpride, paliperidone, quetiapine, risperidone), and High (clozapine, olanzapine); dFrom dietary guidelines published by the Korean Ministry of Health and Welfare [25].

Comparison of characteristics and dietary habits between the obesity and non-obesity groups in men

Characteristics Categories BMI ≥ 30 kg/m2 (n = 26, 17.0%) BMI < 30 kg/m2 (n = 127, 83.0%) χ2 or t p value WC ≥ 90 cm
(n = 57, 37.3%)
WC < 90 cm
(n = 96, 62.7%)
χ2 or t p value
Age Years 38.3 ± 11.4 41.2 ± 11.1 1.225 0.223 40.2 ± 11.5 41.0 ± 11.0 0.452 0.652
Marital status Unmarried 26 (100.0) 118 (92.9) 1.958 0.359 56 (98.2) 88 (91.7) 2.796 0.155
Educationa ≤ 12 years 18 (69.2) 72 (57.6) 1.209 0.271 35 (62.5) 55 (57.9) 0.310 0.577
Employment statusa Unemployed 22 (84.6) 99 (81.1) 0.173 0.786 46 (83.6) 75 (80.6) 0.207 0.649
Medical insurancea Medicaid 16 (61.5) 53 (43.4) 2.820 0.093 29 (51.8) 50 (54.3) 0.092 0.762
Clinical Global Impressiona 1−3 12 (46.2) 49 (39.2) 1.331 0.514 24 (42.1) 37 (39.4) 3.140 0.208
4−5 14 (53.8) 71 (56.8) 33 (57.9) 52 (55.3)
6−7 0 (0.0) 5 (4.0) 0 (0.0) 5 (5.3)
Duration of treatment Years 15.6 ± 9.3 15.7 ± 10.0 0.055 0.956 16.2 ± 9.6 15.4 ± 10.0 −0.521 0.603
Dosage of antipsychoticsb mg/day 6.3 ± 5.1 4.2 ± 3.5 −1.890 0.070 4.9 ± 4.3 4.4 ± 3.7 −0.735 0.463
Weight-gain risk of currently used antipsychoticsa,c Low 3 (13.0) 16 (14.7) 0.452 0.798 6 (12.5) 13 (15.5) 0.395 0.821
Intermediate 15 (65.2) 63 (57.8) 28 (58.3) 50 (59.5)
High 5 (21.7) 30 (27.5) 14 (29.2) 21 (25.0)
Questionnaire for Dietary Habitsd Total 58.8 ± 12.4 64.3 ± 13.2 1.978 0.050 60.0 ± 12.8 65.4 ± 13.1 2.462 0.015
Regular 13.4 ± 5.9 17.3 ± 6.1 2.975 0.003 15.1 ± 5.9 17.5 ± 6.3 2.404 0.017
Balanced 12.2 ± 4.9 14.5 ± 5.6 1.947 0.053 12.9 ± 5.1 14.9 ± 5.7 2.140 0.034
Healthy 33.2 ± 7.3 32.5 ± 6.7 −0.438 0.662 32.1 ± 7.6 33.0 ± 6.3 0.797 0.427

Values are presented as mean ± standard deviation or number (%).

BMI, body mass index; WC, waist circumference.

aValid percent; bRisperidone equivalent dosage; cAntipsychotics included in each category: Low (aripiprazole, ziprasidone, and haloperidol), Intermediate (amisulpride, paliperidone, quetiapine, risperidone), and High (clozapine, olanzapine); dFrom dietary guidelines published by the Korean Ministry of Health and Welfare [25].

Comparisons of characteristics and dietary habits between the obesity and non-obesity groups in women

Characteristics Categories BMI ≥ 30 kg/m2 (n = 27, 23.1%) BMI < 30 kg/m2 (n = 90, 76.9%) χ2 or t p value WC ≥ 85 Cm
(n = 45, 38.5%)
WC < 85 Cm
(n = 72, 61.5%)
χ2 or t p value
Age Years 41.6 ± 8.7 39.4 ± 11.8 −1.069 0.290 42.5 ± 9.2 38.3 ± 12.0 −2.106 0.037
Marital status Unmarried 21 (77.8) 84 (93.3) 5.460 0.030 37 (82.2) 68 (94.4) 4.494 0.057
Educationa ≤ 12 years 19 (70.4) 52 (59.8) 0.986 0.321 31 (68.9) 40 (58.0) 1.382 0.240
Employment statusa Unemployed 25 (96.2) 70 (78.7) 4.290 0.041 35 (79.5) 60 (84.5) 0.465 0.495
Medical insurancea Medicaid 13 (50.0) 46 (52.3) 0.042 0.839 24 (57.1) 35 (48.6) 0.773 0.379
Clinical Global Impressiona 1−3 7 (26.9) 30 (34.9) 0.572 0.751 11 (26.8) 26 (36.6) 1.512 0.470
4−5 17 (65.4) 50 (58.1) 26 (63.4) 41 (57.7)
6−7 2 (7.7) 6 (7.0) 4 (9.8) 4 (5.6)
Duration of treatment Years 15.9 ± 7.6 14.8 ± 11.0 −0.567 0.573 16.1 ± 9.4 14.4 ± 10.8 −0.860 0.392
Dosage of antipsychoticsb mg/d 5.1 ± 4.3 5.3 ± 4.5 0.272 0.786 5.4 ± 4.6 5.2 ± 4.3 −0.291 0.772
Weight-gain risk of currently used antipsychoticsa,c Low 6 (23.1) 10 (13.2) 1.483 0.476 10 (25.0) 6 (9.7) 4.577 0.101
Intermediate 15 (57.7) 51 (67.1) 24 (60.0) 42 (67.7)
High 5 (19.2) 15 (19.7) 6 (15.0) 14 (22.6)
Questionnaire for Dietary Habitsd Total 64.1 ± 12.7 67.0 ± 13.1 1.000 0.319 62.6 ± 12.6 68.7 ± 12.8 2.503 0.014
Regular 17.8 ± 6.9 16.9 ± 6.4 −0.645 0.520 16.3 ± 6.9 17.6 ± 6.2 1.067 0.288
Balanced 14.5 ± 5.7 14.7 ± 6.1 0.164 0.870 13.3 ± 5.7 15.5 ± 6.0 1.965 0.052
Healthy 31.8 ± 6.5 35.4 ± 6.0 2.666 0.009 33.0 ± 6.8 35.5 ± 5.7 2.162 0.033

Values are presented as mean ± standard deviation or number (%).

BMI, body mass index; WC, waist circumference.

aValid percent; bRisperidone equivalent dosage; cAntipsychotics included in each category: Low (aripiprazole, ziprasidone, and haloperidol), Intermediate (amisulpride, paliperidone, quetiapine, risperidone), and High (clozapine, olanzapine); dFrom dietary guidelines published by the Korean Ministry of Health and Welfare [25].

Logistic regression analysis of factors associated with general and abdominal obesity

Characteristics Men Women


General obesity Abdominal obesity General obesity Abdominal obesity




OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value
Age 0.9 (0.9−1.0) 0.513 0.9 (0.9−1.0) 0.159 0.9 (0.9−1.0) 0.979 1.0 (0.9−1.0) 0.375
Medical insurance 0.4 (0.1−1.5) 0.212 1.0 (0.4−2.4) 0.987
Marital status 3.6 (0.7−17.2) 0.097 3.1 (0.7−13.1) 0.115
Duration of treatment 1.0 (0.9−1.1) 0.298 1.0 (1.0−1.1) 0.037
Employment status 0.1 (0.0−1.0) 0.054 1.2 (0.4−3.5) 0.654
Dosage of antipsychotics 1.1 (1.0−1.3) 0.023 1.0 (0.9−1.1) 0.582
Duration of treatment 1.0 (0.9−1.0) 0.740 0.9 (0.9−1.0) 0.861
Regular eating habit 0.8 (0.7−0.9) 0.005 0.9 (0.8−0.9) 0.010 1.0 (0.9−1.1) 0.412 1.0 (0.9−1.0) 0.986
Balanced eating habit 0.8 (0.7−1.0) 0.063 0.9 (0.8−1.0) 0.272 0.9 (0.8−1.0) 0.485 0.9 (0.8−1.0) 0.180
Healthy eating habit 0.9 (0.9−1.0) 0.915 0.9 (0.8−1.0) 0.168 0.8 (0.8−0.9) 0.011 0.9 (0.8−0.9) 0.040

OR (95% CI), odds ratio (95% confidence interval).

References
  1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2224-2260.
    Pubmed KoreaMed CrossRef
  2. World Health Organization. Global status report on noncommunicable diseases 2014.
    Pubmed KoreaMed CrossRef
  3. DE Hert M, Schreurs V, Vancampfort D, VAN Winkel R. Metabolic syndrome in people with schizophrenia: a review. World Psychiatry 2009;8:15-22.
    Pubmed KoreaMed CrossRef
  4. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000;177:212-217.
    Pubmed CrossRef
  5. Bergman RN, Kim SP, Hsu IR, Catalano KJ, Chiu JD, Kabir M, et al. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. Am J Med 2007;120(2 Suppl 1):S3-S8; discussion S29-S32.
    Pubmed CrossRef
  6. Weiden PJ, Mackell JA, McDonnell DD. Obesity as a risk factor for antipsychotic noncompliance. Schizophr Res 2004;66:51-57.
    Pubmed CrossRef
  7. Wong MM, Chen EY, Lui SS, Tso S. Medication adherence and subjective weight perception in patients with first-episode psychotic disorder. Clin Schizophr Relat Psychoses 2011;5:135-141.
    Pubmed CrossRef
  8. Limosin F, Gasquet I, Leguay D, Azorin JM, Rouillon F. Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia. Acta Psychiatr Scand 2008;118:19-25.
    Pubmed CrossRef
  9. Cohen D, De Hert M. Endogenic and iatrogenic diabetes mellitus in drug-naïve schizophrenia: the role of olanzapine and its place in the psychopharmacological treatment algorithm. Neuropsychopharmacology 2011;36:2368-2369.
    Pubmed KoreaMed CrossRef
  10. Lin SH, Tseng HH, Tsai HC, Chi MH, Lee IH, Chen PS, et al. Positive symptoms in antipsychotic-naïve schizophrenia are associated with increased body mass index after treatment. Clin Psychopharmacol Neurosci 2021;19:155-159.
    Pubmed KoreaMed CrossRef
  11. Schulz M, Nöthlings U, Hoffmann K, Bergmann MM, Boeing H. Identification of a food pattern characterized by high-fiber and low-fat food choices associated with low prospective weight change in the EPIC-Potsdam cohort. J Nutr 2005;135:1183-1189.
    Pubmed CrossRef
  12. Yahia N, Achkar A, Abdallah A, Rizk S. Eating habits and obesity among Lebanese university students. Nutr J 2008;7:32.
    Pubmed KoreaMed CrossRef
  13. Cho SJ, Kim JN, Park SJ, Shin WS. Smartphone usage influences the eating habits of middle school students. J Korean Diet Assoc 2018;24:199-211.
  14. Dipasquale S, Pariante CM, Dazzan P, Aguglia E, McGuire P, Mondelli V. The dietary pattern of patients with schizophrenia: a systematic review. J Psychiatr Res 2013;47:197-207.
    Pubmed CrossRef
  15. Kim EJ, Lim SY, Lee HJ, Lee JY, Choi S, Kim SY, et al. Low dietary intake of n-3 fatty acids, niacin, folate, and vitamin C in Korean patients with schizophrenia and the development of dietary guidelines for schizophrenia. Nutr Res 2017;45:10-18.
    Pubmed CrossRef
  16. Provencher V, Drapeau V, Tremblay A, Després JP, Lemieux S. Eating behaviors and indexes of body composition in men and women from the Québec family study. Obes Res 2003;11:783-792.
    Pubmed CrossRef
  17. Yoo S, Cho HJ, Khang YH. General and abdominal obesity in South Korea, 1998-2007: gender and socioeconomic differ-ences. Prev Med 2010;51:460-465.
    Pubmed CrossRef
  18. Faulkner G, Cohn T, Remington G. Validation of a physical activity assessment tool for individuals with schizophrenia. Schizophr Res 2006;82:225-231.
    Pubmed CrossRef
  19. Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Després JP. A single threshold value of waist girth identifies normal- weight and overweight subjects with excess visceral adipose tissue. Am J Clin Nutr 1996;64:685-693.
    Pubmed CrossRef
  20. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 2004;79:379-384.
    Pubmed CrossRef
  21. Kato MM, Currier MB, Villaverde O, Gonzalez-Blanco M. The relation between body fat distribution and cardiovascular risk factors in patients with schizophrenia: a cross-sectional pilot study. Prim Care Companion J Clin Psychiatry 2005;7:115-118; quiz 119-120.
    Pubmed KoreaMed CrossRef
  22. Guy W. ECDEU assessment manual for psychopharmacology. Rockville:U.S. Department of Health & Human Services;1976.
    CrossRef
  23. Musil R, Obermeier M, Russ P, Hamerle M. Weight gain and antipsychotics: a drug safety review. Expert Opin Drug Saf 2015;14:73-96.
    Pubmed CrossRef
  24. Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry 2010;67:255-262.
    Pubmed KoreaMed CrossRef
  25. Ministry of Health and Welfare. Dietary guidelines for Korean adults. Sejong:Ministry of Health and Welfare;2010.
    CrossRef
  26. World Health Organization. Body mass index- BMI [Internet]. Geneva: World Health Organization; 2021 [cited at 2021 Jun 11]. https://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi.
  27. Korean Society for the Study of Obesity. Treatment guidelines 2018. Seoul:Korean Society for the Study of Obesity;2018. Seoul:Korean.
    CrossRef
  28. American Diabetes Association; American Psychiatric Asso-ciation; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004;27:596-601.
    Pubmed CrossRef
  29. Korea Disease Control and Prevention Agency. Korea health statistics 2019. The 2019 Korean National Health and Nutrition Examination Survey [Internet]. Cheongju: Korea Disease Control and Prevention Agency; 2020 [cited at 2021 May 14]. https://knhanes.kdca.go.kr/knhanes/sub04/sub04_04_01.do.
  30. Strassnig M, Brar JS, Ganguli R. Nutritional assessment of patients with schizophrenia: a preliminary study. Schizophr Bull 2003;29:393-397.
    Pubmed CrossRef
  31. Simonelli-Muñoz AJ, Fortea MI, Salorio P, Gallego-Gomez JI, Sánchez-Bautista S, Balanza S. Dietary habits of patients with schizophrenia: a self-reported questionnaire survey. Int J Ment Health Nurs 2012;21:220-228.
    Pubmed CrossRef
  32. Masheb RM, Grilo CM. Eating patterns and breakfast consumption in obese patients with binge eating disorder. Behav Res Ther 2006;44:1545-1553.
    Pubmed CrossRef
  33. Strassnig M, Singh Brar J, Ganguli R. Dietary fatty acid and antioxidant intake in community-dwelling patients suffering from schizophrenia. Schizophr Res 2005;76:343-351.
    Pubmed CrossRef
  34. Roick C, Fritz-Wieacker A, Matschinger H, Heider D, Schindler J, Riedel-Heller S, et al. Health habits of patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol 2007;42:268-276.
    Pubmed CrossRef
  35. Hall KD. Did the food environment cause the obesity epidemic? Obesity (Silver Spring) 2018;26:11-13.
    Pubmed KoreaMed CrossRef
  36. Anderson AL, Harris TB, Tylavsky FA, Perry SE, Houston DK, Hue TF, et al. Dietary patterns and survival of older adults. J Am Diet Assoc 2011;111:84-91.
    Pubmed KoreaMed CrossRef
  37. Masella R, Malorni W. Gender-related differences in dietary habits. Clin Manag Issues 2017;11:59-62.
    CrossRef
  38. Kim YH, Ryu S, Nam HJ, Kim M, Jhon M, Lee JY, et al. The psychology of food cravings in patients with first-episode psy-chosis. Front Psychiatry 2020;11:587486.
    Pubmed KoreaMed CrossRef
  39. El Ansari W, Adetunji H, Oskrochi R. Food and mental health: relationship between food and perceived stress and depressive symptoms among university students in the United Kingdom. Cent Eur J Public Health 2014;22:90-97.
    Pubmed CrossRef
  40. Paans NPG, Gibson-Smith D, Bot M, van Strien T, Brouwer IA, Visser M, et al. Depression and eating styles are independently associated with dietary intake. Appetite 2019;134:103-110.
    Pubmed CrossRef
  41. Jakobsen AS, Speyer H, Nørgaard HCB, Karlsen M, Hjorthøj C, Krogh J, et al. Dietary patterns and physical activity in people with schizophrenia and increased waist circumference. Schizophr Res 2018;199:109-115.
    Pubmed CrossRef
  42. Krishnadas R, Jauhar S, Telfer S, Shivashankar S, McCreadie RG. Nicotine dependence and illness severity in schizophrenia. Br J Psychiatry 2012;201:306-312.
    Pubmed CrossRef
  43. Boyle MA, Holben DH. Community nutrition in action : an entrepreneurial approach. 6th ed. Boston:Cengage Learning;2012.
  44. Kim SW, Park WY, Jhon M, Kim M, Lee JY, Kim SY, et al. Physical health literacy and health-related behaviors in patients with psychosis. Clin Psychopharmacol Neurosci 2019;17:279-287.
    Pubmed KoreaMed CrossRef


This Article

Close ✕


Cited By Articles

Author ORCID Information

Funding Information

Services
Social Network Service

e-submission

Archives